vs

Side-by-side financial comparison of Galecto, Inc. (GLTO) and Jianzhi Education Technology Group Co Ltd (JZ). Click either name above to swap in a different company.

Jianzhi Education Technology Group Co Ltd is the larger business by last-quarter revenue ($1.1M vs $1.0M, roughly 1.1× Galecto, Inc.). Jianzhi Education Technology Group Co Ltd runs the higher net margin — -111.1% vs -20053.5%, a 19942.4% gap on every dollar of revenue.

Galecto Biotech is a biotechnology company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer and inflammation. The company was founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark. The company today is incorporated in the U.S., and has its operating headquarters in Copenhagen, Denmark.

Jianzhi Education Technology Group Co Ltd is a China-based education technology provider focused on vocational training services. It offers professional qualification exam preparation courses, practical skill upgrading programs, and digital learning resources tailored for learners across industries including finance, information technology, and education, serving primarily the domestic Chinese market.

GLTO vs JZ — Head-to-Head

Bigger by revenue
JZ
JZ
1.1× larger
JZ
$1.1M
$1.0M
GLTO
Higher net margin
JZ
JZ
19942.4% more per $
JZ
-111.1%
-20053.5%
GLTO

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
GLTO
GLTO
JZ
JZ
Revenue
$1.0M
$1.1M
Net Profit
$-200.7M
$-1.2M
Gross Margin
19.8%
Operating Margin
-20149.5%
-115.2%
Net Margin
-20053.5%
-111.1%
Revenue YoY
339.0%
Net Profit YoY
-2877.8%
EPS (diluted)
$10.86
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GLTO
GLTO
JZ
JZ
Q4 25
$1.0M
Q2 25
$1.1M
Q4 24
$228.0K
Q3 24
$146.0K
Q2 24
$213.0K
$4.0M
Q1 24
$257.0K
Q4 23
$340.0K
Q3 23
$473.0K
Net Profit
GLTO
GLTO
JZ
JZ
Q4 25
$-200.7M
Q2 25
$-1.2M
Q4 24
$-6.7M
Q3 24
$-3.9M
Q2 24
$-5.3M
Q1 24
$-5.5M
Q4 23
$-6.5M
Q3 23
$-8.1M
Gross Margin
GLTO
GLTO
JZ
JZ
Q4 25
Q2 25
19.8%
Q4 24
Q3 24
Q2 24
19.9%
Q1 24
Q4 23
Q3 23
Operating Margin
GLTO
GLTO
JZ
JZ
Q4 25
-20149.5%
Q2 25
-115.2%
Q4 24
-3114.9%
Q3 24
-2630.1%
Q2 24
-2618.3%
Q1 24
-2233.9%
Q4 23
-1962.1%
Q3 23
-1814.6%
Net Margin
GLTO
GLTO
JZ
JZ
Q4 25
-20053.5%
Q2 25
-111.1%
Q4 24
-2956.6%
Q3 24
-2659.6%
Q2 24
-2506.1%
Q1 24
-2131.1%
Q4 23
-1904.4%
Q3 23
-1720.1%
EPS (diluted)
GLTO
GLTO
JZ
JZ
Q4 25
$10.86
Q2 25
$-0.01
Q4 24
$-5.17
Q3 24
$-3.39
Q2 24
$-4.92
Q1 24
$-5.05
Q4 23
$-27.66
Q3 23
$-7.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GLTO
GLTO
JZ
JZ
Cash + ST InvestmentsLiquidity on hand
$257.6M
$985.5K
Total DebtLower is stronger
Stockholders' EquityBook value
$240.4M
$2.1M
Total Assets
$260.5M
$8.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GLTO
GLTO
JZ
JZ
Q4 25
$257.6M
Q2 25
$985.5K
Q4 24
$14.2M
Q3 24
$19.7M
Q2 24
Q1 24
$27.2M
Q4 23
$33.2M
Q3 23
$44.2M
Stockholders' Equity
GLTO
GLTO
JZ
JZ
Q4 25
$240.4M
Q2 25
$2.1M
Q4 24
$15.8M
Q3 24
$20.9M
Q2 24
$23.6M
$961.1K
Q1 24
$28.2M
Q4 23
$32.3M
Q3 23
$37.4M
Total Assets
GLTO
GLTO
JZ
JZ
Q4 25
$260.5M
Q2 25
$8.0M
Q4 24
$17.1M
Q3 24
$23.4M
Q2 24
$2.8M
Q1 24
$32.5M
Q4 23
$38.2M
Q3 23
$50.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GLTO
GLTO
JZ
JZ
Operating Cash FlowLast quarter
$566.0K
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-171.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GLTO
GLTO
JZ
JZ
Q4 25
$566.0K
Q2 25
$-1.8M
Q4 24
$-4.9M
Q3 24
$-3.7M
Q2 24
$-4.1M
Q1 24
$-5.9M
Q4 23
$-11.5M
Q3 23
$-8.5M
Free Cash Flow
GLTO
GLTO
JZ
JZ
Q4 25
Q2 25
$-1.8M
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
FCF Margin
GLTO
GLTO
JZ
JZ
Q4 25
Q2 25
-171.5%
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Capex Intensity
GLTO
GLTO
JZ
JZ
Q4 25
Q2 25
0.1%
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons